论文信息 - A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea. - 字舞流文

A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea.

C. Singer | B. Jilma | L. Wildt | B. Böttcher | R. Smith | K. Buhling | P. Griffin | M. Schulz | R. Laterza | W. Hill | R. Seufert | Ludwig Wildt | Christian F. Singer